MOLLIE DOCKERY: Open Payments
NPI 1811602279 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 22 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $325 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| Lundbeck LLC | 2 | $50 |
| PFIZER INC. | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Eisai Inc. | 1 | $19 |
Products named: VRAYLAR, REXULTI, LEQEMBI, QULIPTA, UBRELVY, Symbravo, RECORLEV, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
